Risedronate sodium, a bisphosphonate medicine, is prescribed for the treatment of two conditions which affect the bones. It is prescribed as a treatment for ‘thinning’ of the bones (osteoporosis), and it is also used to prevent bone damage in people with Paget’s disease of bone.
Uses: OSTEOPOROSIS
IUPAC: (1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid